PARP1 and skin basal cell carcinoma: Our previous research in ex vivo human skin indicated that PARPi-FL, a poly(adenosine diphosphate ribose) polymerase 1 (PARP1) inhibitor–targeted fluorescent contrast agent, penetrated intact skin when applied topically and improved the diagnosis of BCC compared with reflectance confocal microscopy alone.